Coagulopathy in trauma patients: Importance of thrombocyte function?

Current Opinion in Anaesthesiology

Volumn 22, Issue 2, 2009, Pages 261-266

  Davenport, Ross A ^a   Brohi, Karim ^a,b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Coagulopathy; Haemorrhage; Platelets; Transfusion; Trauma

Indexed keywords

BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD SMEAR; CLINICAL PROTOCOL; ERYTHROCYTE TRANSFUSION; HEMOSTASIS; HUMAN; INJURY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESUSCITATION; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; THROMBIN TIME; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE DYSFUNCTION; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE; THROMBOCYTE TRANSFUSION;

BLOOD COAGULATION DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PLATELETS; HEMOSTASIS; HUMANS; PLATELET COUNT; PLATELET TRANSFUSION; WOUNDS AND INJURIES;

EID: 68049085793     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e328325a6d9     Document Type: Review

References (59)

1. Schouten M, Wiersinga W, Levi M, van der Poll T. Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2008; 83:536-554. This is a contemporary review of the interplay that exists between the inflammatory and coagulation pathways in sepsis.
2. Nurden AT, Nurden P, Sanchez M, et al. Platelets in wound healing. Front Biosci 2008; 13:3532-3548.
3. Hess J, Brohi K, Dutton R, et al. The coagulopathy of trauma: a review of mechanisms. J Trauma 2008; 65:748-754. This review provides an update on the current understanding of TIC and examines the possible initiators and mechanism of this condition.
4. Holcomb J, Wade C, Michalek, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patents. Ann Surg 2008; 248:447-458. This retrospective study analyses the differences in outcome between early large vs. low-volume plasma and platelets replacement in massive blood transfusions following trauma.
5. Gunter O, Brigham K, Isbell J, et al. Optimizing outcomes in damage control resuscitation: identifying blood product ratios associated with improved survival. J Trauma 2008; 65:527-534. This study examines survival differences in patients receiving massive transfusion before and after institution of a specific trauma exsanguinations protocol with increased fresh frozen plasma:packed RBC and platelet:packed RBC ratios.
6. Borgman M, Spinella P, Jerkins J, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007; 63:805-813. This is the first study to evaluate early high-volumefresh frozen plasma and associated outcomes with high fresh frozen plasma: packed RBC ratios in severe trauma.
7. Maegele M, Lefering R, Paffrath T, et al. Red blood cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiply injury: a retrospective analysis from the Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie. Vox Sang 2008; 95:112-119.
8. Davie E, Ratnoff O. Waterfall sequence for intrinsic blood clotting. Science 1964; 145:1310-1312.
9. MacFarlane R. An enzyme cascade in the blood clotting mechanism, and its function as a biological amplifier. Nature 1964; 202:498-499.
10. Monroe D, Hoffman M. What does it take to make the perfect clot? Arterioscler Thromb Vasc Biol 2005; 25:2463-2546.
11. Mann K, Cawthern K, Butenas S. The role of tissue factor pathway in initiation of coagulation. Blood Coagul Fibrinolysis 1998; 9 (Suppl 1):S3-S7.
12. Furie B, Furie B. Mechanisms of thrombus formation. N Engl J Med 2008; 359:938-949. This is a contemporary review of the role of platelets and blood coagulation in thrombus formation.
13. Savage B, Almus-Jacobs F, Ruggeri Z. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 1998; 94:657-666.
14. Ruggeri Z. The role of von Willebrand factor in thrombus formation. Thromb Res 2007; 120:S5-S9.
15. Massberg S, Gawaz M, Gruner S, et al. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 2003; 197:41-49.
16. Monroe DM, Hoffman M, Roberts HR. Transmission of a procoagulant signal from tissue factor-bearing cell to platelets. Blood Coagul Fibrinolysis 1996; 7:459-464.
17. Varga-Szabo D, Pleines I, Nieswandt B. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 2008; 28:403-412. A review of the mechanisms of platelet adhesion to the vessel wall, platelet aggregation and intracellular activation pathways.
18. Bevers E, Comfurius P, Zwaal R. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983; 736:57-66.
19. Hung D, Vu T, Wheaton V, et al. Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation. J Clin Invest 1992; 89:1350-1353.
20. Heemskerk J, Bevers E, Linhout T. Platelet activation and blood coagulation. Thromb Haemost 2002; 88:186-193.
21. Morel O, Morel N, Freyssinet J-M, Toti F. Platelet microparticle and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses. Platelets 2008; 19:9-23. A contemporary review of platelet function and the role of microparticles in haemostasis and thrombosis. The origin, interaction with vascular cells and pathophysiological significance of platelet-derived microparticles are examined in detail.
22. Lösche W. Platelets and tissue factor. Platelets 2005; 16:313-319.
23. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma 2003; 54:1127-1130.
24. MacLeod JB, Lynn M, McKenney MG, et al. Early coagulopathy predicts mortality in trauma. J Trauma 2003; 55:39-44.
25. Maegele M, Lefering R, Yucel N, et al. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury 2007; 38:298-304. This recent, large retrospective review confirmed the existence of an early coagulopathy and recognized its association with mortality and organ failure.
26. Brohi K, Cohen MJ, Ganter MT, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008; 64:1211-1217. This study characterized the thrombotic, coagulant and fibrinolytic derangements of trauma-related hypotension.
27. Brohi K, Cohen MJ, Ganter MT, et al. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg 2007; 245:812-818. This study identified hypoperfusion as the initiator of acute coagulopathy, characterized it as a systemic anticoagulation and hyperfibrinolysis and suggested activation of protein C as the putative mechanism.
28. Oshita K, Az-ma T, Osawa Y, Yuge O. Quantitative measurement of thromboelastography as a function of platelet count. Anesth Analg 1999; 89:296-299.
29. Bowbrick V, Mikhailidis D, Stansby G. Influence of platelet count and activity on thromboelastography parameters. Platelets 2003; 14:219-224.
30. Van Beek J, Mushkudiani N, Steyerberg E, et al. Prognostic value of admission laboratory parameters in traumatic brain injury: results from the IMPACT study. J Neurotrauma 2007; 24:315-328.
31. Brohi K, Cohen M, Davenport R. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care 2007; 13:680-685. This review examines the possible initiators, mechanism and clinical importance of acute coagulopathy of trauma.
32. Kyoko Oshita K, Az-ma T, Osawa Y. Quantitative measurement of thromboelastography as a function of platelet count. Anesth Analg 1999; 89:296-299.
33. Plotkin A, Wade C, Jenkins D, et al. A reduction in clot formation rate and strength assessed by thrombelastography is indicative of transfusion requirements in patients with penetrating injuries. J Trauma 2008; 64:S64-S68. This is a study comparing standard coagulation tests, platelet count and TEG in the prediction of blood transfusion following penetrating trauma.
34. Rugeri L, Levrat A, Delecroix D, et al. Diagnosis of early coagulation abnormalities in trauma patients by rotation thromboelastography. J Thromb Haemost 2007; 5:289-295. This is a study of the use of TEM in early trauma coagulopathy.
35. Chakroun T, Gerotziafas G, Seghatchian J, et al. The influence of fibrin polymerization and platelet-mediated contractile forces on citrated whole blood thromboelastography profile. Thromb Haemost 2006; 95:822-828.
36. Duke W. The relation of blood platelets to hemorrhagic disease. Description of a method for determining the bleeding time and the coagulation time and report of three cases of hemorrhagic disease relieved by blood transfusion. JAMA 1910; 55:1185-1192.
37. Rodgers R, Levin J. A critical appraisal of the bleeding time. Semin Thromb Hemost 1990; 16:1-20.
38. Jennings L, White M. Platelet aggregation. In: Michleson AD, editor. Platelets, 2nd ed. San Diego, CA: Elsevier/Academic Press; 2006. pp. 495-508.
39. Mengistu A, Wolf M, Boldt J, et al. Evaluation of a new platelet function analyzer in cardiac surgery: a comparison of modified thromboelastography and whole-blood aggregometry. J Cardiothorac Vasc Anesth 2008; 22:40-46.
40. Harrison P, Frelinger A, Furman M, Michelson A. Measuring antiplatelet effects in the laboratory. Thromb Res 2007; 120:323-336. A review evaluating all platelet function analysers and their role in monitoring antiplatelet agents.
41. Ganter M, Hofer C. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008; 106:1366-1375. A contemporary review evaluating viscoelastic measures of clot strength and clot breakdown in the identification and management of bleeding.
42. Tantry U, Bliden K, Guyer K. Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachodonic acid stimulation. J Am Coll Cardiol 2005; 46:1820-1826.
43. Craft R, Chavez J, Breese S, et al. A novel modification of the thromboelastograph assay, isolating platelet function, correlates with optical platelet aggregation. J Lab Clin Med 2004; 143:301-309.
44. Jacoby R, Owings J, Holmes J, et al. Platelet activation and function after trauma. J Trauma 2001; 51:639-647.
45. Nekludov M, Bellander B, Blombäck M, Wallen HL. Platelet dysfunction in patients with severe traumatic brain injury. J Neurotrauma 2007; 24:1699-1706.
46. The guide to the preparation, use and quality assurance of blood components. 13th ed. Strasbourg, France: Council of Europe; 2007. pp. 15-28.
47. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of platelet transfusions. Br J Haematol 2003; 122:10-23.
48. Cauwenberghs S, van Pampus E, Curvers J. Hemostatic and signalling functions of transfused platelets. Transfus Med Rev 2007; 4:287-294. A review examining the loss of platelet function associated with storage and potential strategies to improve efficacy of platelet transfusions.
49. Badlou B, IJseldijk M, Smid W, et al. Prolonged platelet preservation by transient metabolic suppression. Transfusion 2005; 45:214-222.
50. Badlou B, Wu Y, Smid W, et al. Platelet binding and phagocytosis by macrophages. Transfusion 2006; 46:1432-1443.
51. MacLennan S, Williamson L. Risks of fresh frozen plasma and platelets. J Trauma 2006; 60:S46-S50.
52. Norda R, Tynell E, Åkerblom O. Cumulative risks of early fresh frozen plasma, cryoprecipitate and platelet transfusion in Europe. J Trauma 2006; 60:S41-S45.
53. Rebibo D, Simonet M, Hauser L. Introduction of platelet additive solution in platelet concentrates: towards a decrease of blood transfusion reactions. Transfus Clin Biol 2008; 15:289-293.
54. Brecher ME, Hay SN. Improving platelet safety: bacterial contamination of platelets. Curr Hematol Rep 2004; 3:121-127.
55. McCullough J, Vesole DH, Benjamin RJ, et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood 2004; 104:1534-1541.
56. Hiippala S. Replacement of massive blood loss. Vox Sang 1998; 74:399-407.
57. Geeraedts LMG, Demiral H, Schaapb N, et al. 'Blind' transfusion of blood products in exsanguinating trauma patients. Resuscitation 2007; 73:382-388. This study described the insufficient replacement of plasma and platelets associated with empiric massive transfusions.
58. Hess JR, Holcomb JB. Transfusion practice in military trauma. Transfus Med 2008; 18:143-150.
59. Kashuk JL, Moore EE, Johnson JL. Postinjury life threatening coagulopathy: is 1:1 fresh frozen plasma: packed red blood cells the answer? J Trauma 2008; 65:261-271. A review of massive transfusion practice, which indicated the relationship between coagulopathy and mortality cannot be explained by increased fresh frozen plasma:packed RBC ratios alone.